Novo Nordisk Investigational Site

Chattanooga, Tennessee 37404

We've found

1 trials

at this facility

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Chattanooga, TN

Use our guide to learn which trials are right for you!